U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. CDER Conversations
  1. News & Events for Human Drugs

CDER Conversations

Discussions with key Center for Drug Evaluation and Research (CDER) leadership about important regulatory and policy issues

The Latest CDER Conversations

View all

CDER Conversation with Liang Zhao and Mehul Mehta
Setting and Implementing Standards for Narrow Therapeutic Index Drugs

Our experts discuss how CDER helps ensure the dosage range of narrow therapeutic index (NTI) drugs falls within a safe and effective therapeutic window, and the challenges and opportunities in developing NTI generic drugs.

Read more


Dark blue graphic with white and gold text overlay. Text reads CDER Conversation with Alexandria Smith. An image of Alexandria's headshot is on the left hand side of the graphic.
Optimizing Drug Information Through Target Audience Feedback

Alexandria Smith, MSPH, a social scientist with CDER's Research and Risk Communications staff, discusses how our communications testing program helps ensure the information we share is understandable, relevant, trustworthy, and useful.

Read more


Center for Drug Evaluation and Research (CDER) Conversation with Evan Wearne
Opportunities to Enhance Safe and Effective Medication Use

The Office of Medical Policy’s Evan Wearne, PharmD, MS, explains the role that software may play in promoting safe and effective drug use and the future interplay between software and therapeutics.

Read more


CDER Conversation with Theresa Mullin
Creating Harmonized Technical Standards Through Guidelines

Theresa Mullin, PhD, Associate Center Director for CDER’s Strategic Initiatives, talks about CDER’s important work as a Founding Regulatory Member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

Read more


All CDER Conversations

2024

2023

2022

2021

2020

View archived CDER Conversations (2014-2019)

 



Back to Top